0001640455-18-000103.txt : 20180828 0001640455-18-000103.hdr.sgml : 20180828 20180828172828 ACCESSION NUMBER: 0001640455-18-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180827 FILED AS OF DATE: 20180828 DATE AS OF CHANGE: 20180828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drapkin Kimberlee C CENTRAL INDEX KEY: 0001340881 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 181042496 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_153549169199929.xml FORM 4 X0306 4 2018-08-27 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001340881 Drapkin Kimberlee C C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 CFO and Treasurer Common Stock 2018-08-27 4 M 0 12700 2.36 A 27100 D Stock Option (Right to Buy) 2.36 2018-08-27 4 M 0 12700 0 D 2025-08-25 Common Stock 12700.0 213514 D 25% of the option shares vested and became exercisable on August 26, 2016 and the remainder of the option shares vest and become exercisable in 12 quarterly installments thereafter. /s/ Kimberlee C. Drapkin 2018-08-28